U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C50H83NO21
Molecular Weight 1034.1881
Optical Activity UNSPECIFIED
Defined Stereocenters 31 / 31
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TOMATINE

SMILES

[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@@]5([H])C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@]6(CC[C@H](C)CN6)O2)O[C@]7([H])O[C@H](CO)[C@H](O[C@]8([H])O[C@H](CO)[C@@H](O)[C@H](O[C@]9([H])OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O[C@]%10([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O)[C@H](O)[C@H]7O

InChI

InChIKey=REJLGAUYTKNVJM-SGXCCWNXSA-N
InChI=1S/C50H83NO21/c1-20-7-12-50(51-15-20)21(2)32-28(72-50)14-26-24-6-5-22-13-23(8-10-48(22,3)25(24)9-11-49(26,32)4)65-45-40(63)37(60)41(31(18-54)68-45)69-47-43(71-46-39(62)36(59)34(57)29(16-52)66-46)42(35(58)30(17-53)67-47)70-44-38(61)33(56)27(55)19-64-44/h20-47,51-63H,5-19H2,1-4H3/t20-,21-,22-,23-,24+,25-,26-,27+,28-,29+,30+,31+,32-,33-,34+,35+,36-,37+,38+,39+,40+,41-,42-,43+,44-,45+,46-,47-,48-,49-,50-/m0/s1

HIDE SMILES / InChI

Description

Alpha (α)-tomatine (simply tomatine) is the major saponin and occurs naturally in tomatoes, possesses a variety of biological properties including antioxidant, and anti-inflammatory. In additıon, tomatine is also known that it breaks down the cell membrane induces growth inhibition and apoptosis in different cancer cells: myeloid leukemia cells; prostate cancer cells; lung adenocarcinoma cells. However, the mechanisms of α-tomatine actions were not well understood. Nevertheless, was shown, that tomatine inhibited the NF-κB and phosphatidyl-inositol-3-kinase/Akt signaling pathways activation. However, the primary cellular target(s) for α-tomatine and its mechanisms for modulating apoptosis-associated pathways remain to be elucidated. The interaction of α-tomatine with cholesterol and the disruptive effect on the cell membrane may be one of the mechanisms by which α-tomatine induces apoptosis. The formation of complexes of α-tomatine and cholesterol may modulate the responsiveness of cell membrane receptors to growth stimuli and thus decrease the growth of cancer cells. Moreover, the anti-inflammatory mechanisms of α-tomatine, which may be a valuable therapeutic agent in the treatment of inflammation-related diseases was due to the ability of tomatine accelerated the phosphorylation of Akt in macrophages.

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown
Primary
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Male severe combined immunodeficient (SCID) mice bearing PC-3 xenograft tumors were treated with i.p injections with vehicle (5 μl/g body weight), α-tomatine (5 mg/kg), curcumin (5 mg/kg), or α-tomatine (5 mg/kg) + curcumin (5 mg/kg) three times a week for 30 days.
Route of Administration: Intraperitoneal
In Vitro Use Guide
There was evaluated the effect of tomatine on cytotoxicity, apoptosis and matrix metalloproteinase inhibition in MCF-7 cell lines. Human breast cancer cell line (MCF-7) was used as a cell line. In MCF-7 cells, the IC50 dose of tomatine was determined to be 7.07 μM. According to the control cells, apoptosis increased 3.4 fold in 48thh. Activation of MMP-2, MMP-9 and MMP-9\NGAL has been shown to decrease significantly in cells treated with tomatine by gelatin zymography compared to the control. As a result, matrix metalloproteinase activity and cell proliferation were suppressed by tomatine